Le Lézard
Classified in: Health
Subject: PLW

RxFiber llc Announces Issuance of U.S. Patent No. 10,835,645 Covering High-Tenacity Fibers for Use in Sterilized Medical Devices


MERIDIAN, Idaho, Jan. 14, 2021 /PRNewswire-PRWeb/ -- RxFiber LLC, a privately held, biotextile company focused on innovative and differentiated fibers for the medical device industry, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 10,835,645, on November 17, 2020, which is directed to methods related to the production of high tenacity fibers for use in sterilized medical devices.

RxFiber llc's patented high tenacity fiber is marketed as RxFibron HT©, a high tenacity fiber developed to revolutionize sterilized medical devices.

RxFiber llc is actively seeking potential partners to license or purchase the patented technology for the development of lower-profile sterilized devices or other suitable applications.

"We are pleased to have been awarded this important patent that we believe will provide medical device manufacturers an innovative alternative to UHMWPE and standard polyester," says Brenda Gilchrist President of RxFiber llc.

Inventor Robert Torgerson says, "RxFibron HT© has several advantages over existing polyesters, including lower denier, durability, high strength, and custom size variations suitable for creating lower-profile devices."

The revolutionary patented RxFibron HT© is the first commercially available high tenacity, medical grade polyester biomaterial that can be used to create next-generation implantable devices, such as sutures, composites, and more for applications such as endovascular, vascular, and orthopedics.

Ms. Gilchrist, President of RxFiber llc says, "RxFibers' patented high tenacity polyester fiber was invented because physicians were looking for smaller delivery systems to deliver devices in a transcatheter application and mitigate trauma to the patient."

Media Contact

Brenda Gilchrist, RXFIBER, LLC, +1 866-308-6025 Ext: 11, [email protected]

Brenda Gilchrist, RxFiber, LLC, 1-866-308-6025 11, [email protected]

 

SOURCE RxFiber, LLC


These press releases may also interest you

at 21:03
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the latest results from five studies have been selected for...

at 21:00
Bristol Myers Squibb today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Breyanzi® (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment...

at 20:54
Starlight Children's Foundation CEO, Adam Garone, has been named Nonprofit Executive of the Year (Large), by the Los Angeles Business Journal. The prestigious award was presented at the annual Nonprofit and Corporate Citizenship Award luncheon held...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, today announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2...

at 19:56
Rare Cannabinoid Company is proud to announce the launch of its new,...

at 18:58
Children's HealthSM and UT Southwestern Medical Center announced a historic gift of $100 million from the Jean and Mack Pogue family in support of the $5 billion new Dallas pediatric campus, unveiled earlier this year. The gift from the Pogue...



News published on and distributed by: